InspireMD, Inc. NSPR
0.65 USD +0.05 (+8.33%)
Regular-session close
0.66 +0.01 +1.54%
After hours · Nov 17, 7:45 PM ET
0.57 Day range 0.68
0.43 52-week range 2.17
- YTD
- -63.48%
- 1 year
- -67.66%
News
globenewswire.com InspireMD to Host KOL Webinar on Carotid Artery Disease Management and the Clinical Benefits of InspireMD's CGuard Prime Carotid Stent Platform Participating KOLs include six leading physician experts representing vascular surgery, interventional cardiology, vascular medicine, and neurosurgery
zacks.com InspireMD (NSPR) Upgraded to Buy: Here's Why InspireMD (NSPR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
globenewswire.com InspireMD Announces Talks Featuring CGuard and CGuard Prime at VEITHsymposium 2026 MIAMI, Nov. 16, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today…
globenewswire.com InspireMD Announces Pricing of $37.5 Million Public Offering MIAMI, Nov. 13, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) ("InspireMD" or the "Company"), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today…
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session Gainers SELLAS Life Sciences Gr (NASDAQ:SLS) stock rose 19.6% to $9.6 during Friday's pre-market session. The market value of their outstanding shares is at $1.6 billion. As per the news, the Q3…
seekingalpha.com InspireMD, Inc. (NSPR) Q3 2026 Earnings Call Transcript InspireMD, Inc. (NSPR) Q3 2026 Earnings Call Transcript
zacks.com InspireMD, Inc. (NSPR) Reports Q3 Loss, Beats Revenue Estimates InspireMD, Inc. (NSPR) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to a loss of $0.17 per share a year ago.benzinga.com Update: InspireMD Q3 Adj. EPS $(0.11) Beats $(0.15) Estimate, Sales $2.242M Beat $1.996M Estimate InspireMD (NASDAQ:NSPR) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.15) by 26.67 percent. This is a 35.29 percent increase over losses of $(0.17)…
globenewswire.com InspireMD Announces Proposed Public Offering MIAMI, Nov. 12, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today…
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session Gainers Oragenics (AMEX:OGEN) stock increased by 30.2% to $0.46 during Thursday's after-market session. The market value of their outstanding shares is at $1.5 million. InspireMD (NASDAQ:NSPR) shares…benzinga.com InspireMD Q3 EPS $(0.12) Beats $(0.15) Estimate, Sales $2.242M Beat $1.996M Estimate. Cash and Equivalents $19.246M InspireMD (NASDAQ:NSPR) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.15) by 20 percent. This is a 29.41 percent increase over losses of $(0.17) per…
globenewswire.com InspireMD Reports Third Quarter 2026 Financial Results - Received FDA approval of CGuard® Prime for Transcarotid Arterial Revascularization (TCAR) procedures, expected to approximately double the U.S. addressable market - - Company to host investor…
globenewswire.com InspireMD Announces FDA Approval of the CGuard® Prime TransCarotid Stent System for Transcarotid Artery Revascularization (TCAR) Procedures - Approval doubles the CGuard Prime platform's total addressable market in the U.S. with additional access to over 35,000 TCAR procedures annually –
globenewswire.com InspireMD Announces Updated Timing for Third Quarter 2026 Financial Results MIAMI, Nov. 11, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that it has rescheduled its…
benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session Gainers Inovio Pharmaceuticals (NASDAQ:INO) shares rose 211.2% to $1.88 during Monday's regular session. The company's market cap stands at $62.2 million. BeyondSpring (NASDAQ:BYSI) stock moved…
